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A B S T R A C T
Mass spectrometric (MS) approaches developed for tissue identiﬁcation in surgical environments are re-
viewed. MS Imaging (MSI) techniques enable the direct analysis of human tissue and can be used as an
alternative means for margin assessment. While MSI-based approaches were demonstrated to improve
the examiner-related variance of the data, the time demand and the cost of these analyses remained high.
Furthermore, the necessity of MS expertise for the clinical deployment of these techniques has hin-
dered large-scale clinical testing. The advent of ‘ambient’ MS methods contributed to the application of
MSI techniques in this ﬁeld, however alternative methods have been developed for the direct analysis
of tissue samples without sample preparation. One group of methods employs surgical tissue manipu-
lation for ionization while the other one uses minimally invasive probes for sampling prior to ionization.
The methods are summarised and compared with regard to the information delivered, turnaround time
and tissue identiﬁcation performance.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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1. Introduction
The presence of cancer cells on the edge of the surgical resec-
tionmargins (positivemargins) is usually conﬁrmed by postoperative
histopathological examination of the resected tissue with results
only available after the surgery has ﬁnished. Nevertheless, histo-
pathological examination is also available during the surgical
procedure, however its reliability is inferior compared to that of post-
operative approaches. Traditional histopathological techniques to
provide a tissue diagnosis during surgery include frozen section and
imprint cytology. Frozen section analysis involves rapid freezing,
cutting, staining and examination of a section of tissue. Imprint cy-
tology involves touching excised tissue or ﬂuid to a slide and both
are based on microscopic assessment by a highly skilled patholo-
gist. These techniques for intraoperative margin assessment
(summarized in Table 1) are time consuming, laborious and
Abbreviations: 2-HG, 2-hydroxyglutarate; CBS-MS, coated blade spray mass spec-
trometry; CT, computed tomography; CUSA, Cavitron ultrasonic surgical aspirator;
DESI, desorption electrospray ionization; DESI-MS, desorption electrospray ioniza-
tion mass spectrometry; DESI-MSI, desorption electrospray ionization mass
spectrometry imaging; IDH1, isocitrate dehydrogenase 1; LC-MS, liquid
chromatrographymass spectrometry; LDI-MS, laser desorption ionization-mass spec-
trometry; MALDI, matrix-assisted laser desorption/ionization; MALDI-MS, matrix-
assisted laser desorption/ionization mass spectrometry; MALDI-MSI, matrix-
assisted laser desorption/ionization mass spectrometry imaging; MS, mass
spectrometry or mass spectrometric; MSI, mass spectrometry/spectrometric imaging;
PESI-MS, probe electrospray ionization mass spectrometry; PS-MS, paper spray mass
spectrometry; REIMS, rapid evaporative ionization mass spectrometry; RF, radio fre-
quency; SESI, secondary electrospray ionization; SIMS, secondary ion mass
spectrometry; SPME, solid phasemicroextraction; V-EASI, Venturi easy ambient sonic-
spray ionization.
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subjective. Positive margins are, however, directly linked to a higher
rate of local/regional recurrence and require a further operation to
remove the remaining cancerous tissue. In breast surgery, where
the current trend is to conserve as much healthy tissue as possi-
ble, the overall re-operation rate is about 20% or over [1, 2]. Based
on the number of recent publications on intraoperative margin iden-
tiﬁcation, assessing margins is most relevant in breast, neurological,
urological, upper gastrointestinal, colorectal and skin cancers. Due
to the importance of margin assessment, recent research has ac-
tively focused on novel margin detection technologies using a variety
of analytical techniques in addition to traditional histology. Broadly
these can be divided into medical imaging techniques, optical spec-
troscopy, radiofrequency spectroscopy andmass spectrometry (MS).
Traditional methods for tissue identiﬁcation are based on de-
tecting morphological changes in different tissue types. In addition
to changes in structure and form, cells in different tissues have highly
speciﬁc chemical composition, which can easily be proﬁled using
mass spectrometric techniques. In the last few years development
of novel techniques and instrumentation for mass spectrometry has
led to the ability to detect proteins and metabolites directly from
tissues using desorption ionization techniques, paving the way to
the development of intraoperative mass spectrometric approaches.
Currently developed methods fall into three main categories in-
cluding intraoperative imaging, surgical device-based ionization
techniques and solid sampling probes for subsequent MS analysis.
The current review follows this structure for the description of the
individual approaches.
2. Discussion
2.1. Mass spectrometric imaging
Various mass spectrometry techniques have successfully been
used to characterize tumor microenvironment and margin involve-
ment in ex vivo samples (Table 2). Many of these are mass
spectrometry imaging (MSI) approaches, which use aworkﬂow based
on traditional histology, displayed in Fig. 1. In these cases, tissue
specimens collected intraoperatively are ﬂash-frozen and sec-
tioned. However, instead of using staining andmicroscopy to identify
the cell types present, the sections are analysed by MSI, obtaining
spatially resolved chemical information. The aim of these experi-
ments is to detect certain mass spectrometric peaks or spectral
patterns typical for the tumor tissue or tissue inﬁltrated by cancer
cells. In recent years, imaging mass spectrometry has undergone
tremendous development with regard to speed of analysis, sensi-
tivity and spatial resolution. Furthermore, the improved performance
characteristics enabled conducting large scale, properly powered
imaging studies which provided broad evidence for the histologi-
cal speciﬁcity of MSI data, paving the ways for the intraoperative
deployment of the technology.
The three most commonly usedMSI techniques in tissue imaging
are secondary ion mass spectrometry (SIMS), matrix-assisted laser
desorption mass spectrometry (MALDI-MS) and desorption
electrospray ionization mass spectrometry (DESI-MS). The ﬁrst of
these to emerge was SIMS, which was originally developed for the
elemental analysis of structured inorganic surfaces [21, 22] in the
1960s. SIMS uses a focussed high energy primary ion beam con-
sisting of ionized atoms or clusters for the desorption and ionization
of species (atoms or molecules) present at the gas/solid interface.
Traditionally SIMS has been used for elemental analysis and de-
tection of organic fragments, but more recently larger projectiles
consisting of thousands of argon atoms have allowed higher sec-
ondary yields and detection of intact molecules up to 2–3 kDa
molecular weight [23]. SIMS allows the highest spatial resolution
of all current MSI techniques [24] however both the preparation of
samples and the analysis itself are complex and time consuming,
which raises serious problems regarding the intraoperative appli-
cability of the method [25–27].
In contrast, MALDI has been routinely used for analysis of tumor
margins and tumormicroenvironment in fresh frozen tumor samples
[28, 29]. Although the method requires the careful deposition of
matrix compound on the surface of the sample, the overall com-
plexity of the analysis workﬂow is signiﬁcantly lower compared to
SIMS. In addition, MALDI readily detects proteins, peptides, complex
lipids and metabolites in a single experiment as it was described
in the case of gastrointestinal [30], respiratory [31], bladder [32],
breast [33], and ovarian [34] cancers, as well as in acute myeloid
leukemia [35]. AlthoughMALDI has also been considered to be time
consuming, the recent commercialization of the Rapiﬂex instru-
ment by Bruker (Massachusetts, United States) reduced the analysis
time of a single sample to a few minutes, opening the door to in-
traoperative deployment of the technology.
In contrast to SIMS and MALDI, DESI is capable of the analysis
of the sample surface under atmospheric pressure and tempera-
ture and it requires minimal or no preparation or pre-treatment [36].
The DESI experiment is implemented by directing a pneumati-
cally assisted solvent electrospray onto the surface of interest. The
incoming droplets accumulate on the surface extracting all soluble
analytes and the impact of further primary droplets produce sec-
ondary droplets which contain the dissolved analyte molecules. The
secondary charged droplets follow an electrospray-like ionization
scenario, yielding mostly electrospray-like spectral data. DESI anal-
ysis of tissue sections produces spectra dominated by complex lipid
species including phospholipids, triglycerides, sphingolipids and
cardiolipins, due to the high concentration and preferred ioniza-
tion of these species. Nevertheless, the histological speciﬁcity of these
Table 1
Intraoperative margin assessment techniques
Technique Reference Time required Sample type (number) Sensitivity Speciﬁcity
Frozen sections [3] 20–25 min Breast (gold standard method for most tumor tissue) 73% 98%
Touch imprint cytology [4] 10 min Breast (used for most tissue types) 89% 92%
Intraoperative ultrasound [5] 3–6 min Breast (also used for other tissue types) 75% 81%
Mohs micrographic surgery [6–8] Facial recurrent basal cell carcinoma 59–100% 81–90%
Digital specimen X-ray [9] 1–20 min Breast (intraoperative specimen mammography) 66% 86%
Micro-computed tomography [10] 7 min Breast (Shaved cavity margins, 25 samples) 83% 95%
High frequency ultrasound [11] Breast (Ductal carcinoma, 17 patients) 74% 85%
Diffuse reﬂection spectroscopy [12, 13] Breast (Two studies with 47 specimens and 55 specimens) 90% 88%
Raman spectroscopy [14, 15] 3–5 s Brain and breast tissue 83–93% 91–93%
Optical coherence tomography [16] Breast 100% 82%
Confocal microscopy [17] [18] Brain (33 lesions), bladder 79–90% 67–88%
RF impedance spectroscopy [19, 20] Breast 70–75% 56–70%
Table 1 displays examples of current and emerging intraoperative margin assessment techniques. Legend: RF = Radio-frequency.
3E.R. St John et al. / Trends in Analytical Chemistry 85 (2016) 2–9
Table 2
Mass Spectrometry in biological samples, techniques with potential relevance to Intraoperative Mass Spectrometry
Year/Ref MS Method Ion mode (mass range) Biological sample Analytes detected Number of samples (S) or
patients (Pt)
Imaging Time demands of anlalysis
Matrix assisted laser desorption ionization imaging mass spectrometry (MALDI-MS)
2014 [49] MALDI-MS +ve Human lung (homogenized frozen samples) 40 peaks that differentiated
cancer and normal tissue
138 Pt and 141 tumour/non-
cancer pairs and 8 unique
cancer samples
No Not available
Matrix assisted laser desorption ionization mass spectrometry imaging (MALDI-MSI)
2013 [50] MALDI-MSI +ve, (400–1,000) Human breast (frozen sections) Lipids 29 Pt and S Yes Not available
2014 [51] MALDI-MSI (50–1,000) Human colorectal (frozen sections) Lipids 12 Pt Yes Not available
2015 [52] MALDI-MSI +ve, (500–30,000) Human pituitary (frozen sections) Protein/Peptide hormones 51 S Yes <30 minutes
Desorption electrospray ionization mass spectrometry (DESI-MS)
2005 [37] DESI-MS +ve Mouse pancreas, rat brain and human liver
adenocarcinoma (frozen sections)
Lipids Animal tissue, a case study of
human liver adenocarcinoma
No Less than 5 seconds per spot
2013 [53] DESI-MS Not available Rat brain, kidneys and intestine (frozen sections) Lipids Animal tissue No 0.5 seconds (Immediate
analysis in laboratory)
2014 [39] DESI-MS Depends on analyte Human brain gliomas (frozen tissue- ex vivo,
intraoperative)
2-hydroxyglutarate 35 S ex vivo, 2 S in vivo No Within minutes
Desorption electrospray ionization mass spectrometry imaging (DESI-MSI)
2011 [54] DESI-MSI -ve, (600–1,000) Human brain – tumor tissue (ex vivo, intraoperative,
frozen sections)
Lipids Brain tumor samples from
different locations, one case
study presented
Yes Not available
2012 [46] DESI-MSI -ve and +ve, (200–1,000) Human brain - tumor frozen sections (ex vivo, frozen
sections)
Lipids 55 S ex vivo, 32 S / 5 Pt
intraoperative
Yes Not available
2013 [48] DESI-MSI -ve, (50–1,100) Human brain – Glioblastoma (ex vivo, frozen sections) Lipids 12 S / 1 Pt Yes 1 s
2013 [47] DESI-MSI -ve Human brain – Oligodendroglioma, astrocytoma, and
meningioma tumors (ex vivo, frozen sections)
Lipids 32 S / 5 Pt Yes Less than a a second
2014 [41] DESI-MSI -ve, (90–1,200) Human stomach (frozen sections) Ex vivo: cancer and
normal gastric tissue In vivo: gastric cancer margin
Lipids, small molecules related
to energy production
62 S (ex vivo), 21 S / 9 Pt
(intraoperative)
Yes 0.5 s per pixel
2014 [40] DESI-MSI -ve, (50–1,100) Human breast tissue (ex vivo, frozen sections) Lipids 61 S / 14 Pt Yes Within seconds
2015 [55] DESI-MSI -ve (200–1,000) Human breast (ex vivo, frozen sections) Free fatty acids & Lipids Lesion = 28 S / 28 Pt Tumour
bed = 98 S / 22 Pt
Yes Not available
Surgical ionization techniques
2011 [56] LDI-MS -ve, (150–1,000) Human colon carcinoma metastasis in the liver,
porcine kidney, porcine lung (ex vivo)
Lipids Not available No Not available
2011 [57] V-EASI -ve and +ve, (150-1,000) Human brain – astrocytomas, meningeomas,
metastatic brain tumors and healthy brain tissue and
human liver tumor tissue (ex vivo)
Lipids Not available No 2–3 seconds
2013 [58] REIMS -ve, (600–900) Human: gastric, colorectal, liver, breast, lung and brain
tissue (ex vivo and intraoperative)
Lipids 302 Pt (ex vivo), 81 Pt
(intraoperative)
No 2.5 seconds
Other ionization techniques
2011 [59] PS-MS -ve, (depends on analyte) Rat brain tissue, porcine adrenal gland, mouse liver
tissue, human prostate tumor and normal tissue (ex
vivo)
Hormones, lipids and
therapeutic drugs
Animal tissue, case study of
human prostate tumor and
normal tissue
No Less than 1 minute
2012 [60] PESI-MS Depends on analyte Human Kidney (Frozen homogenized kidney tissue,
intact kidney tissue (ex vivo))
Lipids 9 Pt No 5–15 minutes
2013 [61] PESI-MS -ve, (depends on analyte) Human colon tumor tissue (ex vivo) Lipids and proteins 8 S No Not available
2014 [62] CBS-MS Depends on analyte Phosphate buffered saline spiked with cocaine, human
plasma and urine samples
Cocaine and diazepam (drugs) Phosphate buffered saline,
plasma and urine samples
No Less than 3 minutes
2015 [63] SPME-MS -ve Individual small organisms (Daphnia magna) Perﬂuorooctanesu-lfonic acid
and perﬂuorooctanoic acid
28 S No Within minutes
2016 [64] SPME-MS Depends on analyte Phosphate buffered saline spiked with cocaine and
diazepam
Phosphate buffered saline Plasma and urine samples = 2S No Within minutes
Table 2 details studies with potential application to intraoperative mass spectrometry. Legend: CBS-MS coated blade spray mass spectrometry, CUSA Cavitron ultrasonic surgical aspirator, DESI-MS desorption electrospray ion-
ization mass spectrometry, DESI-MSI desorption electrospray ionization mass spectrometry imaging, MALDI-MS matrix-assisted laser desorption/ionization mass spectrometry, MALDI-MSI matrix-assisted laser desorption/
ionization mass spectrometry imaging, REIMS rapid evaporative ionization mass spectrometry, LDI-MS laser desorption ionization-mass spectrometry, V-EASI Venturi easy ambient sonic-spray ionization, PESI-MS probe electrospray
ionization mass spectrometry, PS-MS paper spray mass spectrometry, SPME solid phase microextraction, Ref references.
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lipid proﬁles obtained by DESI-MSI has been demonstrated in the
case of liver cancer [37], prostate cancer [38], brain tumors [39],
breast cancer [40] and gastrointestinal tumors [41]. In one of these
studies, DESI-MSwas used tomeasure differences in levels of a polar
metabolite, 2-hydroxyglutarate, providing evidence that the tech-
nique is capable of detecting non-lipid type species [39]. The
metabolite, which is derived from α-ketoglutarate, is known to ac-
cumulate in leukemia and speciﬁcally in most grade two and three
gliomas in adult patients due to a mutation in isocitrate dehydro-
genase 1 and 2 and could be used as a biomarker [42, 43]. DESI-
MS was able to identify an increase in 2-HG that was independent
of the exact mutation of IDH1. This compares well with immuno-
histology which is only able to recognize certain types of the many
IDH1 mutants using a speciﬁc antibody (anti-IDH1 R132H [44]). An
intraoperative model for the detection of the biomarker was con-
structed and increased levels of 2-HG were detected from
intraoperative samples of glioma containing a mutation in IDH1 in
the operating room. Using DESI-MS installed within the operating
room, the group was able to detect 2-HG within minutes from in-
traoperative glioma specimens containing mutant variants of
IDH1 [39]. N-acetyl-aspartic acid, detected using DESI-MS in neu-
rological specimen smears, is another recent example of an
oncometabolite that has been used to help differentiate between
brain parenchyma [45]. Furthermore, this same study demon-
strated that multivariate statistical analysis of spectra from a
combination of lipids and oncometabolites including 2-HG re-
sulted in accurate differentiation between tumour type (glioma,
meningioma and pituitary) with an overall sensitivity of 99.4% and
a speciﬁcity of 99.7%. These are just a few examples demonstrat-
ing how chemical proﬁles obtained from tissue have potential to
offer additional information compared to traditional histology.
In another experiment, statistical analysis of DESI-MS data was
able to differentiate between gliomas (oligodendrogliomas, astro-
cytomas and oligoastrocytomas) representing a variety of grades
using lipid species such as fatty acids, glycerophosphoinositols,
glycerophoserines, plasmenyl phosphoethanolamines and sulfatides
[46]. Classiﬁers constructed frommultivariate statistical analysis of
spectral signatures and correlated with histopathology revealed a
high cross-validated predictive accuracy of 97% for tumor type, grade
and cellular concentration. Models based on lipid proﬁles have pro-
vided similar results when distinguishing gliomas frommeningiomas
[47], necrotic tumor tissue from viable glioblastomamultiforme [48]
and in breast cancer margin assessment [40]. The authors of the
studies concluded analysis in the negative ionmode revealed greater
sensitivity for the detection of lipids and metabolite species [40, 41,
46, 48].
MSI techniques have provided large quantities of data that is
highly relevant to tissue identiﬁcation in a histological setting and
understanding biological processes in cancer-host tissue systems.
However, with the exception of tissue smears, the current MSI tech-
niques require preparation of frozen tissue sections prior to analysis.
All procedures can lead to spatial dislocation of chemical species
or modiﬁcation of the chemical proﬁle on the tissue and prepara-
tion via frozen section adds signiﬁcantly to the time it takes to
analyse a sample, since a single section is rarely representative for
the status of the entire surgical margin. This inability to produce
results within the timeframe of the operation as well as the re-
quirements arising from sample preparation limit their usefulness
for intraoperative margin assessment. Fig. 1 illustrates an opti-
mized MSI workﬂow.
2.2. Intraoperative mass spectrometry
While MSI techniques demonstrate the potential of mass spec-
trometry for rapid proteomic or lipidomic phenotyping of tissues
yielding histologically relevant information, their clinical transla-
tion to surgical applications is seriously hindered by the complexity
and time demand of these approaches. Nevertheless, on the basis
of this potential, a range of ambient ionization techniques better
suited for surgical use have been developed (Table 2). These tech-
niques generally utilize surgical tissue manipulation methods for
the ionization of cellular component, eliminating the need to in-
troduce novel tools into the surgical area and offering the possibility
of in-situ, real-time analysis. The rationale of thesemethods is based
on the consideration that the rapid thermal or mechanical disin-
tegrationof aqueous systems (e.g. tissuesorbiologicalﬂuids)produces
charged droplets, which can eventually yield gas phase ions upon
theevaporationof theaqueousphase. Thesemechanismsareassumed
Fig. 1. Mass spectrometric imaging workﬂow. An optimized MSI workﬂow is displayed. The process involves surgical excision of the specimen, gross preparation of spec-
imen followed cryosection and mounting on slides. Tissue on slides are analysed by MSI method. After MS analysis slides can be sent for secondary pathological assessment.
MS images can be assessed intraoperatively for surgical decision making.
5E.R. St John et al. / Trends in Analytical Chemistry 85 (2016) 2–9
to be similar to that of sonic sprayor thermospray (off-ﬁlamentmode)
ionization methods. Since most surgical tissue dissection methods
(with the obvious exception of surgical scalpels) thermally or me-
chanically disintegrate tissues, they were also expected to function
as ion sources. The development of these techniques for intraop-
erative tissue identiﬁcation thusonly required theadditionof a suction
line to the surgical handpieces and providing eﬃcient means for
ion/aerosol transfer to amass spectrometer installed severalmeters
away from the patient. Similarly to the abovementioned sonic spray
ionization and thermospray ionization techniques, various surgical
techniques including laser surgery, electrosurgery or ultrasonic tissue
ablation produce low intensity but still informative mass spectra
upon the introduction of the resulting aerosol into a mass spec-
trometer equippedwith an atmospheric interface. The eﬃciency of
ion yield was successfully improved by inducing surface-induced
dissociation of aerosol particles in the atmospheric interface of the
instrument or by secondary electrospray (SESI) post-ionization. The
discovery that various surgical tools incidentally cause ionization
of tissues during routine surgical use has been of great signiﬁcance
and these techniques are described below.
Laser desorption ionization-mass spectrometry (LDI-MS) has orig-
inally been developed in the 1970’s primarily for elemental analysis
purposes, and later it was successfully used also for the ionization
of organic molecules including components of biological tissues. In-
strumentation capable of LDI-MSI was developed in the early 1980’s.
The advent of MALDI in the late 1980’s, however effectively halted
the further development of LDI-based tissue analysis and the tech-
nique (in the form of laser surgery) was re-discovered around 2010
as a potential platform for intraoperative tissue identiﬁcation [56].
The employed CO2 lasers are one of the most common lasers used
in a variety of surgical procedures, since they offer precise cutting
and coagulation with minimal thermal spread. Recent advance-
ments have heralded the ﬂexible CO2 laser that enables use in awider
range of applications including brain and endoscopic surgeries [65,
66]. Aerosol is produced as a direct results of laser application on
tissue and can be aspirated continuously into a mass spectrome-
ter. Analysis of ex vivo samples of human liver colorectal metastasis
and human renal cell carcinoma using CO2 LDI-MS showed good sep-
aration between cancer and surrounding healthy tissues using
supervised multivariate statistical methods. The technique is not
limited to CO2 lasers, practically any lasers with wavelengths
in the 190–580 nm and above 2 μm produces ions on the ablation
of biological tissues. The resulting spectral data features ions cor-
responding to various lipid compounds, similarly to SIMS or DESI.
It’s important to point out that no photochemical effects or wave-
length dependence of spectral patterns were observed, supporting
a largely thermal ionization mechanism [56].
Cavitron ultrasonic surgical aspirator (CUSA) has also been suc-
cessfully coupled with on-line MS analysis of dissected tissue
material. The technique uses ultrasound to induce the mechanical
disruption of tissues combined with a continuous ﬂushing mech-
anism to clear away the resultant tissue debris. Primarily used in
neurosurgery it works as a precise technique for selectively excis-
ing parenchymal tissue whilst sparing blood vessels, it can also be
used in operations targeting the liver and pancreas. The technique
was coupled with MS by transferring and aerosolizing the tissue
debris using a Venturi ﬂuid pump for both functions [57]. The
pneumatic spraying of the sample was shown to produce ions cor-
responding to predominantly complex lipid species. Other small
molecules not readily detected by other ambient ionization mass
spectrometry techniques using a thermal process were also de-
tected. The technique has been used to analyse ex vivo brain and
liver samples [57]. A clear difference was seen between spectra cor-
responding to grey and white brain matter as well as different types
of brain tumors. Liver tumors also separated well from healthy liver
parenchyma. The analysis was performed in 2–3 seconds from CUSA
application, leading to near instant measurements that are signiﬁ-
cantly faster than the sample preparation for DESI-MS described in
a previous paper [54].
The third surgical modality serving as a potential ion source is
electrosurgery or electrosurgical diathermy [58]. This technique
utilises radiofrequency (>100 kHz) alternating electric current for
the dissection of tissues and coagulation of minor blood vessels. The
mass spectrometric analysis of electrosurgical aerosols was ﬁrst de-
scribed in 2008 and the combination was termed Rapid Evaporative
IonizationMass Spectrometry (REIMS). REIMS is implemented either
by directly aspirating electrosurgical aerosol into the MS using the
suction force generated by the vacuum system or can also be de-
livered to the instrument by Venturi pump. REIMS has been
extensively tested to date by analysing thousands of ex vivo speci-
mens consisting of normal and cancerous tissue. The reports feature
healthy and cancerous tissues from stomach, colon, liver, lung and
breast samples among others. Spectral data shows intensive signal
in the mass range 600–900 representing predominantly lipids, sim-
ilarly to data produced by many other direct ionization approaches.
The sensitivity and speciﬁcity of the method was reported to range
from 69% for mixed adenosquamous cell carcinoma to 100% for
healthy tissue from lung and liver [58]. Further validation was ob-
tained by acquiring in vivo data in the operating theatre for 81
patients. The sensitivities and speciﬁcities from this analysis ranged
between 95–100% and 92–100% respectively. All data points were
acquired and analysed within 2.5 seconds, resulting in near real time
feedback during surgical intervention. Fig. 2 illustrates an opti-
mized surgical ionization workﬂow.
2.3. Sampling probe-based methods
A persistent problem encountered in the analysis of biological
tissue is access to tissue features without surgically exposing them.
For most techniques, a physical sample has to be either exposed or
removed from the body prior to MS analysis. A group of MSmethods
employing needle geometry sampling probes can provide a solu-
tion for this problem (Table 2). The sampling needle in this case is
introduced into the tissues from a few mm to few cm depth and
analysed either directly or following solvent extraction. The sim-
plest implementation of the approach is probe electrospray ionization
mass spectrometry (PESI-MS), which uses a small probe or solid
needle for sampling and subsequent electrospray ionization [67].
The technique was used for analysis of ex vivo samples of human
clean renal cell carcinoma: tissue was placed onto a sampling stage
and a solid needle was lowered into the sample and then raised out
to allow application of high voltage and subsequent electrospray
ionization. The cancerous regions in the sample were correctly iden-
tiﬁed when correlated with histopathology. Interestingly,
comparisons between homogenised samples and intact speci-
mens revealed similar spectral proﬁles suggesting that intracellular
lipids could be measured without homogenisation [60]. Following
on from this work the same group developed a new method incor-
porating their PESI-MS design in negative ionmodewith an auxiliary
side solvent vapour sprayer using isopropanol-H2O. Principal com-
ponent analysis showed deﬁned separation of cancerous and normal
colon tissues [61]. While capable of rapid identiﬁcation of suﬃ-
cient lipid proﬁles to classify normal and tumor tissue [61] and even
analysis of metabolites in single cells [68], these techniques aremore
suited for analysis of biopsy samples. Fig. 3 illustrates an opti-
mized probe base ionziation workﬂow.
The sampling probe can also carry an absorbent layer to improve
selectivity and sensitivity of the tissue extraction. Solid phase
microextraction (SPME) devices are well suited for this purpose and
the utilization of SPME technology for intraoperative tissue iden-
tiﬁcation was reported recently. A thin and ﬂexible probe was made
with a core built from titanium-nickel alloy and a biocompatible
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co-polymer for the extraction substance that coats part of the probe.
The probes are directly immersed into the tissues and eluted fol-
lowing the tissue extraction step. The eluates are analysed by LC/
MS, however the SPME can also be used similarly to PESI or can be
directly analysed by DESI-MS. The technique allows for the extrac-
tion of small metabolites and drugs with molecular weights of up
to 1000 Da. These probes have been successfully used for the in-
traoperative analysis of a wide range of metabolites during lung and
liver transplantation in porcine models [69]. Levels of endogenous
compounds and drugs revealed changes in relation to cold isch-
emic time, perfusion and reperfusion. Although this technique has
not yet been used in in vivo human tissue, it is easy to see how this
simple technique is readily translatable to human surgical appli-
cations and could augment or replace the traditional core biopsy
procedure.
An advantage of SPME based analysis is that the coatings can
extract both polar and non-polar compounds. This technique is also
ideally suited for the extraction of small-molecular-weight analytes
which enables detection both of endogenous and pharmacologic
molecules [70]. Previously, rapid analysis of the sample from the
SPME probe was a challenge. Coated blade spray (CBS) ionization
mass spectrometry was developed speciﬁcally for the rapid anal-
ysis of SPME samples and was demonstrated to improve the speed
of analysis to within 3 minutes[62]. A stainless steel blade coated
with the biocompatible polymer C18-polyacrylonitrile (C18-PAN) is
preconditioned in a methanol and water mix. The blade is then in-
serted into the sample matrix and agitated with a vortex for 1
minute. Following this the blade is rinsed in water prior to
desorption/ionization initiated by the passing a high voltage through
the blade. Recently, the same group has coupled SPME ﬁbres with
Fig. 2. Surgical ionization workﬂow. An optimized surgical ionization workﬂow is displayed. A surgical tool is used as per standard operating procedure. Surgical aerosol is
aspirated and delivered to the mass spectrometer. MS analysis is performed, results are interpreted by multivariate statistical models and displayed on screen for imme-
diate feedback to the surgeon.
Fig. 3. Probe based ionization workﬂow. An optimized probe based ionization workﬂow is displayed. A probe is inserted into the appropriate tissue for approximately 2-20
minutes allowing the diffusion of analytes onto the sampling matrix. The probe is extracted, a solvent added and a voltage applied. Ionized spray is aspirated into the MS
for analysis. Mass spectra are acquired for interpretation by multivariate statistics. Results are fed back to the surgeon for intraoperative decision making.
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the use of nano-electrospray ionization (nano-ESI) decreasing sample
preparation time to 2 minutes [64]. Accurate results are demon-
strated for probe analysis in phosphate-buffered saline (PBS), urine,
and whole blood. The technique is readily applicable to tissue biopsy
or bioﬂuids within the operating room, however, work is also un-
derway to investigate the use of SPME-nano-ESI as a rapid diagnostic
technique in vivo.
This class of rapid mass spectrometry techniques additionally
includes paper spray mass spectrometry (PS-MS) which utilizes a
cellulose-based adsorbent and on-probe electrospray. PS-MS process
comprises placing the sample onto a triangular strip of porous paper
for a few seconds and applying a solvent and a high voltage across
the paper inducing an electrospray of charged ions that is aspi-
rated into a mass spectrometer for analysis [59]. The technique was
demonstrated to yield histologically speciﬁc mass spectral data in
less than a minute. Due to the large amount of liquid present in the
surgical area the PS method suits better for the analysis of core or
pinch biopsy specimens.
3. Conclusion
Mass spectrometric analysis of tissues in the surgical environ-
ment is a rapidly developing ﬁeld. Although there are a number of
different technologies which are potentially able to replace the cur-
rently used tissue morphology-based approach, mass spectrometry
shows a few unique advantages including the short response time
and the molecularly resolved nature of resulting information. The
latter opens the way to integrate the mass spectrometric proﬁles
into themolecular cancer diagnostic infrastructure by properly iden-
tifying signiﬁcant peaks and linking them to the expression of
proteins (enzymes, receptors, transporters) or mutations in genes
encoding them.
The current major roadblock regarding the clinical translation
of mass spectrometry-based tissue proﬁling techniques is mostly
associated with the unclear regulatory background for multivari-
atemethods and the lack of multicentre studies reported in literature.
Additional considerationsmay arise from the requirements for main-
tenance of the instruments and development of suitable data
processing workﬂows. Frequent use will demand regular cleaning
and servicing cycles that will need to become rapid, simpliﬁed and
ideally automated. Data processing workﬂows will need to provide
validated, actionable results, quick enough to guide clinical deci-
sion making. The identiﬁcation of the molecular background of MS
information and further spreading of the technologies in the bio-
medical world will likely solve these problems in the course of the
following 5–10 years.
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